Primary |
Product Used For Unknown Indication |
23.2% |
Pain |
16.1% |
Diabetic Neuropathy |
13.5% |
Back Pain |
7.7% |
Hypertension |
7.7% |
Diabetes Mellitus |
3.8% |
Hypercholesterolaemia |
3.5% |
Multiple Allergies |
3.3% |
Coronary Artery Disease |
2.9% |
Arthralgia |
2.7% |
Gastrooesophageal Reflux Disease |
2.7% |
Type 2 Diabetes Mellitus |
2.6% |
Nutritional Support |
1.8% |
Prophylaxis |
1.5% |
Cancer Pain |
1.3% |
Cardiovascular Event Prophylaxis |
1.3% |
Post-traumatic Pain |
1.3% |
Cardiac Valve Disease |
1.1% |
Depression |
1.1% |
Medical Diet |
1.1% |
|
Gastrointestinal Disorder |
10.6% |
Somnolence |
7.6% |
Vision Blurred |
7.6% |
Death |
6.1% |
Dyspnoea |
6.1% |
Electrocardiogram Change |
6.1% |
Hypertension |
6.1% |
Suicidal Ideation |
6.1% |
Toxicity To Various Agents |
6.1% |
Depression |
4.5% |
Fall |
4.5% |
Nausea |
4.5% |
Completed Suicide |
3.0% |
Convulsion |
3.0% |
Diarrhoea |
3.0% |
Drug Ineffective |
3.0% |
Lip Ulceration |
3.0% |
Malaise |
3.0% |
Myalgia |
3.0% |
Orthostatic Intolerance |
3.0% |
|
Secondary |
Diabetic Neuropathy |
19.7% |
Pain |
14.9% |
Product Used For Unknown Indication |
12.2% |
Hypertension |
11.4% |
Type 2 Diabetes Mellitus |
5.1% |
Diabetes Mellitus |
4.4% |
Hypercholesterolaemia |
4.2% |
Multiple Allergies |
4.1% |
Gastrooesophageal Reflux Disease |
3.8% |
Back Pain |
3.2% |
Arthralgia |
2.9% |
Coronary Artery Disease |
2.1% |
Nutritional Support |
2.0% |
Prophylaxis |
1.8% |
Depression |
1.6% |
Cardiovascular Event Prophylaxis |
1.4% |
Cardiac Valve Disease |
1.4% |
Post-traumatic Pain |
1.3% |
Medical Diet |
1.2% |
Neuralgia |
1.2% |
|
Gastrointestinal Disorder |
26.3% |
Vision Blurred |
9.6% |
Hypertension |
8.1% |
Completed Suicide |
7.1% |
Suicidal Ideation |
6.1% |
Death |
5.1% |
Tachycardia |
5.1% |
Toxicity To Various Agents |
5.1% |
Fall |
4.5% |
Diarrhoea |
3.0% |
Dehydration |
2.5% |
Heart Rate Increased |
2.5% |
Spinal Cord Compression |
2.5% |
Electrocardiogram Change |
2.0% |
Gait Disturbance |
2.0% |
Orthostatic Intolerance |
2.0% |
Vomiting |
2.0% |
Drug Hypersensitivity |
1.5% |
Hypoglycaemia |
1.5% |
Nausea |
1.5% |
|
Concomitant |
Product Used For Unknown Indication |
26.4% |
Pain |
17.6% |
Metastatic Malignant Melanoma |
7.5% |
Neuralgia |
4.4% |
Sleep Disorder |
4.4% |
Complex Regional Pain Syndrome |
3.8% |
Depression |
3.8% |
Pancreatic Carcinoma |
3.8% |
Plasma Cell Myeloma |
3.1% |
Vomiting |
3.1% |
Back Pain |
2.5% |
Chronic Myeloid Leukaemia |
2.5% |
Hypertension |
2.5% |
Insomnia |
2.5% |
Pyrexia |
2.5% |
Blood Cholesterol Increased |
1.9% |
Fibromyalgia |
1.9% |
Gastric Disorder |
1.9% |
Hypersensitivity |
1.9% |
Nausea |
1.9% |
|
Vomiting |
12.5% |
Pain |
9.4% |
Stress Cardiomyopathy |
9.4% |
Intervertebral Disc Protrusion |
6.3% |
Road Traffic Accident |
6.3% |
Tachypnoea |
6.3% |
Vision Blurred |
6.3% |
Weight Increased |
6.3% |
Alopecia |
3.1% |
Asthenia |
3.1% |
Cardiovascular Disorder |
3.1% |
Chest Pain |
3.1% |
Circumstance Or Information Capable Of Leading To Medication Error |
3.1% |
Death |
3.1% |
Disorientation |
3.1% |
Dizziness |
3.1% |
Drug Ineffective |
3.1% |
Dysgeusia |
3.1% |
Ear Infection |
3.1% |
Fall |
3.1% |
|
Interacting |
Pain |
50.0% |
Product Used For Unknown Indication |
50.0% |
|
|